Expanding applications: GLP-1s are now being explored beyond metabolic diseases, including liver disease (e.g., MASH/NAFLD), cardiovascular health, sleep apnea, alcohol use disorder, and potentially reducing obesity-related cancer risk
The FDA ended broad enforcement discretion tied to shortages
Consult a Healthcare Professional Before starting any supplementation, talk to your doctor, especially if you: Are pregnant or breastfeeding Have kidney or liver disease Have known food allergies Take prescription medications Have a history of kidney stones 2
Gutbrain axis: how the microbiome influences anxiety and depression
[These products] may promise results similar to those of clinically tested medications like GLP-1 receptor agonists without undergoing the same level of scrutiny and testing, Stanford said
On the sport side, both compounds fall within the scope of anti-doping prohibition